These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 20021538)

  • 1. Pathogenesis and pathophysiology of the cardiometabolic syndrome.
    Kirk EP; Klein S
    J Clin Hypertens (Greenwich); 2009 Dec; 11(12):761-5. PubMed ID: 20021538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically Healthy and Unhealthy Normal Weight and Obesity.
    Stefan N
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):487-493. PubMed ID: 32814419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
    Thyfault JP; Rector RS; Noland RC
    J Cardiometab Syndr; 2006; 1(3):184-9. PubMed ID: 17679820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic risk: a Framingham perspective.
    Wilson PW; Meigs JB
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S17-20. PubMed ID: 18469835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of the insulin resistance syndrome.
    Meigs JB
    Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in nonalcoholic fatty liver disease.
    Bugianesi E; Moscatiello S; Ciaravella MF; Marchesini G
    Curr Pharm Des; 2010 Jun; 16(17):1941-51. PubMed ID: 20370677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.
    Holvoet P
    Verh K Acad Geneeskd Belg; 2008; 70(3):193-219. PubMed ID: 18669160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications.
    Eschwège E
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S19-27. PubMed ID: 14502097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
    Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
    J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome and type 2 diabetes: role of the adipocyte.
    McPherson R; Jones PH
    Curr Opin Lipidol; 2003 Dec; 14(6):549-53. PubMed ID: 14624130
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiometabolic risk management in type 2 diabetes and obesity.
    Taylor AM
    Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
    Sowers JR; Frohlich ED
    Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).
    Steinberger J; Daniels SR; ;
    Circulation; 2003 Mar; 107(10):1448-53. PubMed ID: 12642369
    [No Abstract]   [Full Text] [Related]  

  • 17. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dysmetabolic syndrome: epidemiology and etiology.
    Sauerwein HP
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD.
    Eckel RH
    Proc Nutr Soc; 2007 Feb; 66(1):82-95. PubMed ID: 17343775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.